Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis.
Paolo PalmiscianoAli S HaiderChibueze D NwagwuWaseem WahoodSalah G AounKalil G AbdullahTarek Y El AhmadiehPublished in: Journal of neuro-oncology (2021)
Bevacizumab and LITT can be safe and effective treatments for RN from brain metastases. Clinical and radiological outcomes are mostly comparable, but LITT may relate with superior survival benefits in select patients. Further studies are required to identify the best patient candidates for each treatment group.
Keyphrases
- brain metastases
- small cell lung cancer
- end stage renal disease
- ejection fraction
- chronic kidney disease
- metastatic colorectal cancer
- prognostic factors
- subarachnoid hemorrhage
- type diabetes
- metabolic syndrome
- stem cells
- bone marrow
- radiation therapy
- mesenchymal stem cells
- mass spectrometry
- free survival
- patient reported outcomes